Abstract
In Italy, where it began more than 62 years ago, ECT has almost been abolished. In some countries, however, ECT is still used inappropriately, particularly in elderly patients. There is no medical, moral, or legal justification for ECT, and the new requirements of modern psychiatric practice can all be achieved with-out it. Like prefrontal lobotomy and all previous shock treatments, ECT is nonviable. The death of ECT will help promote mental health and put the treatment where it belongs—in the archaeology of science.
Similar content being viewed by others
References
Youssef HA, Youssef FA. Time to abandon electroconvulsion as a treatment in modern psychiatry.Adv Ther. 1999;16:29–38.
Bourne H. Electroconvulsive therapy ending where it began.Psychiatr Bull. 1999;23:505.
Duffet R, Elliot P. Auditing electroconvulsive therapy. The third cycle.Br J Psychiatry. 1998; 172:401–405.
American Psychiatric Association.Task Force on Electroconvulsive Therapy. Report 14. Washington, DC: American Psychiatric Association; 1978.
Royal College of Psychiatrists. Memorandum on the use of electroconvulsive therapy.Br J Psychiatry. 1977;131:261-272.
Daly M. Electric shock victim wins historic victory.The Big Issue. 1999;10:5.
Fernando S, Storm V. Suicide among psychiatric patients of a district general hospital.Psychol Med. 1984;14:661–672.
Babigian HM, Gurrmacher LB. Epidemiological consideration in electroconvulsive therapy.Arch Gen Psychiatry. 1984;41:246–253.
Heshe J, Roeder I. Electroconvulsive therapy in Denmark.Br J Psychiatry. 1976;128:241–245.
Haddad DM, Benbow SM. Anaesthetists’ views of electroconvulsive therapy clinic.Psychiatr Bull. 1993;17:655–657.
Clyma EA. Unilateral electroconvulsive therapy. How to determine which hemisphere is dominant.Br J Psychiatry. 1975;126:372.
Wilkinson D. ECT in the elderly. In: Holmes L, Howard R, eds.Advances in Old Age Psychiatry: Chromosomes to Community Care. Worthing, UK: Wrighton Biomedical Publishing; 1977:161–171.
Benbow SM. Old age: psychiatrists’ views on the use of ECT.Int J Geriatr Psychiatry. 1991;6: 317–322.
Baxter L, Roy-Byrne D, Liston E, et al. Informing patients about electroconvulsive therapy: effects of video-tape presentation.Convuls Ther. 1977:2:25–29.
Abram R.Electroconvulsive Therapy. Oxford: Oxford University Press; 1988.
Sackeim HA. Use of electroconvulsive therapy in late life depression. In: Schneider LS, ed.Diagnosis and Treatment of Depression in Late Life. Washington, DC: American Psychiatric Press; 1994:259–277.
Squire LR. Memory function as affected by electroconvulsive therapy.Ann N Y Acad Sci. 1966; 466:307–314.
Freeman CP, Kendell RE. ECT: patients’ experience and attitude.Br J Psychiatry. 1980;137:8–16.
Galloway J, Blakey A. Correspondence: ECT in the elderly.Psychiatr Bull. 1998;22:714.
Hobson RF. Prognostic factors in electric convulsive therapy.J Neurol Neurosurg Psychiatry. 1953; 16:275–281.
Sackeim HA, Prudie J, Devanand DP, et al. The impact of medication resistance and continuation of pharmacotherapy on relapse following response to electroconvulsive therapy in major depression.J Clin Psychopharmacol. 1990;10:96–104.
Gangadhar BN, Janakiramiah N, Subbakrishna DK, et al. Twice versus thrice ECT in melancholia: a double blind prospective comparison.J Affect Disord. 1993;27:273–278.
Peretti CS, Danion JM, Grange D, Moubarek N. Bilateral ECT and autobiographical memory of subjective experience related to melancholia: a pilot study.J Affect Disord. 1996;41:9–15.
Post RM, Utide TW, Roy-Byrne PP, Joff RT. Antidepressant effects of carbamazepine.Am J Psychiatry. 1990;143:29–34.
Post RM. Anticonvulsants as adjuncts or alternatives to lithium in refractory bipolar illness. In: Amsterdam JD, ed.Advances in Neuropsychiatry and Psychopharmacology, II. Refractory Depression. New York: Raven Press; 1991:155–165.
McElory SL, Keck PM, Pope HG. Sodium valproate: its use in primary psychiatric disorders.J Clin Psychopharmacol. 1987;8:16–24.
Elphick M, Young JD, Cowen PJ. Effects of carbamazepine on dopamine and serotonin mediated neuroendocrine responses.Arch Gen Psychiatry. 1990;47:135–140.
Post RM, Weiss SR, Chung DM. Mechanism of action of anticonvulsants in affective disorders: comparison with lithium.J Clin Psychopharmacol. 1992;12:23s-35s.
Maitre L, Ballzer V, Mondadori C. Psychopharmacological and behavioural effects of anti-epileptic drugs in animals. In: Emrich HM, Okuma T, Muller A, eds.Anticonvulsants in Affective Disorders. Amsterdam: Elsevier Science; 1984:3–13.
Cook LC. Convulsion therapy.J Ment Sci. 1944;90:435–464.
Sackeim HA, Prudie J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.N Engl J Med. 1993;328:839–848.
Grahame-Smith DG, Green AR, Costain DW. Mechanism of the antidepressant action of electroconvulsive therapy.Lancet. 1978;i:254–256.
Green AR, Heal DJ, Goodwin GM. The effect of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain: similarities and differences. In:Antidepressants and Receptor Function. Chichester, UK: Wiley; 1986;123:246–267. Ciba Foundation Symposium.
Szasz TS. From the slaughter house to the mad house.Psychother Theory Res Pract. 1971;8:64–67.
Taylor JR, Carrol JL. Current issues in electroconvulsive therapy.Psychol Rep. 1987;60:747–758.
Lishman WA.Organic Psychiatry: The Psychological Consequences of Cerebral Disorder. London: Blackwell Scientific; 1987:111.
Johnstone EC, Deakin JF, Lawler P, et al. The Northwick Park Electroconvulsive Therapy Trial.Lancet. 1980;ii:1317–1320.
ECT in Britain: a shameful state of affairs.Lancet. 1981;ii:1207.
Templer DI. ECT and brain damage: how much risk is acceptable?Behav Brain Sci. 1984;7:39.
Fink M. ECT—Verdict: not guilty.Behav Brain Sci. 1984;7:26–27.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Youssef, H., Youssef, F. The death of electroconvulsive therapy. Adv Therapy 18, 83–89 (2001). https://doi.org/10.1007/BF02852392
Issue Date:
DOI: https://doi.org/10.1007/BF02852392